Insmed (INSM) Shares Outstanding (2010 - 2026)

Insmed's Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $216.5 million for Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 19.03% year-over-year to $216.5 million in Q1 2026; TTM through Mar 2026 was $216.5 million, a 19.03% increase from a year earlier, with the FY2025 full-year figure at $214.3 million, up 19.44% from the prior year.
• Shares Outstanding (Entity) rose to $216.5 million in Q1 2026 per INSM's latest filing, from $214.3 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $216.5 million in Q1 2026 and bottomed at $119.3 million in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $148.6 million (2024), against an average of $163.3 million.
• Across the five-year window, Shares Outstanding (Entity) increased 2.85% in 2022 and rose 26.67% in 2025, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $135.7 million in 2022, then gained by 9.09% to $148.0 million in 2023, then increased by 21.22% to $179.4 million in 2024, then climbed by 19.44% to $214.3 million in 2025, then increased by 1.06% to $216.5 million in 2026.
• Per Business Quant, the three latest INSM Shares Outstanding (Entity) figures stand at $216.5 million (Q1 2026), $214.3 million (Q4 2025), and $212.6 million (Q3 2025).